Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
A von Eckardstein, … , H Funke, G Assmann
A von Eckardstein, … , H Funke, G Assmann
Published May 1, 1991
Citation Information: J Clin Invest. 1991;87(5):1724-1731. https://doi.org/10.1172/JCI115190.
View: Text | PDF
Research Article

Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.

  • Text
  • PDF
Abstract

Apolipoprotein C-III is a major protein constituent of triglyceride rich lipoproteins and HDL. It occurs in plasma in three isoforms differing by their sialic acid content. Apo C-III putatively inhibits lipolysis and the apo E mediated hepatic uptake of remnants from triglyceride rich particles. We identified a heterozygous carrier of an apolipoprotein C-III variant by the presence of additional bands after isoelectric focusing (IEF) of VLDL. Structural analysis of the variant protein by HPLC, time-of-flight secondary ion mass spectrometry, and automated gas phase sequencing revealed a lysine to glutamic acid replacement in position 58. The underlying A to G exchange was verified by direct sequencing subsequent to amplification by polymerase chain reaction of exon 4 of the apo C-III gene. Family studies revealed vertical transmission of this defect. The two variant carriers exhibited plasma concentrations of HDL cholesterol and apo A-I above the 95th percentiles of sex matched controls whereas the unaffected father and sister showed normal values. The plasma concentrations of apo C-III in the two variant carriers were decreased by 30-40% compared with those of the two unaffected family members and to random controls. Using two-dimensional immunoelectrophoresis as well as IEF and subsequent scanning densitometry, we found that the low serum concentration of apo C-III was a consequence of diminished concentrations of the variant apo C-III isoproteins in both VLDL (15% of normal) and HDL (25% of normal). Apo C-III(Lys58----Glu) heterozygotes possessed unusual HDL as demonstrated by nondenaturing gradient gel electrophoresis. They consisted mainly of HDL2b and contained a proportion of atypically large particles, enriched in apo E, with a Stokes diameter of 13-18 nm and resembling HDLc. In conclusion, heterozygosity for a structural apo C-III variant--apo C-III(Lys58----Glu)--was identified in two hyperalphalipoproteinemic subjects characterized by the presence of low plasma apo C-III concentrations and atypically large HDL.

Authors

A von Eckardstein, H Holz, M Sandkamp, W Weng, H Funke, G Assmann

×

Total citations by year

Year: 2024 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2000 1999 1998 1997 1995 1994 1993 1992 1991 Total
Citations: 1 1 1 9 1 1 2 2 1 1 6 3 5 2 2 4 1 1 2 2 2 4 4 1 1 3 7 3 2 1 76
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (76)

Title and authors Publication Year
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.
Packard CJ, Pirillo A, Tsimikas S, Ference BA, Catapano AL
Cardiovascular research 2024
Genetics and regulation of HDL metabolism
D Kardassis, E Thymiakou, A Chroni
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2022
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases
A Giammanco, D Noto, CM Barbagallo, E Nardi, R Caldarella, M Ciaccio, MR Averna, AB Cefalù
Life Sciences 2021
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang
2020
Metabolic characterisation of disturbances in the APOC3/triglyceride-rich lipoprotein pathway through sample-based recall by genotype
LJ Corbin, DA Hughes, AJ Chetwynd, AE Taylor, AD Southam, A Jankevics, RJ Weber, A Groom, WB Dunn, NJ Timpson
Metabolomics 2020
ApoCIII: A multifaceted protein in cardiometabolic disease
DE Laura, DC Alessia, A Gallo, E Bruckert, A Marcello
Metabolism 2020
HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling
A Chroni, D Kardassis
Current medicinal chemistry 2019
Non-alcoholic fatty liver disease: a narrative review of genetics
Christopher J Danford, Ze-Min Yao, Z Gordon Jiang
Journal of Biomedical Research 2018
The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation
M Sundaram, KR Curtis, MA Alipour, ND LeBlond, KD Margison, RA Yaworski, RJ Parks, AD McIntyre, RA Hegele, MD Fullerton, Z Yao
Journal of lipid research 2017
Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition
NL Meyers, M Larsson, E Vorrsjö, G Olivecrona, DM Small
Journal of lipid research 2017
Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy
W Annema, A Eckardstein
Translational Research 2016
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile
S Valleix, G Verona, N Jourde-Chiche, B Nédelec, PP Mangione, F Bridoux, A Mangé, A Dogan, JM Goujon, M Lhomme, C Dauteuille, M Chabert, R Porcari, CA Waudby, A Relini, PJ Talmud, O Kovrov, G Olivecrona, M Stoppini, J Christodoulou, PN Hawkins, G Grateau, M Delpech, A Kontush, JD Gillmore, AD Kalopissis, V Bellotti
Nature Communications 2016
Apolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates
HF Raposo, AA Paiva, LS Kato, HC de Oliveira
Nutrition & Metabolism 2015
Glycomic Analysis of High Density Lipoprotein Shows a Highly Sialylated Particle
J Huang, H Lee, AM Zivkovic, JT Smilowitz, N Rivera, JB German, CB Lebrilla
Journal of Proteome Research 2014
Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics
DB Larach, M Cuchel, DJ Rader
Clinical Lipidology 2013
Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly
D Hesse, K Radloff, A Jaschke, M Lagerpusch, B Chung, A Tailleux, B Staels, A Schurmann
Journal of lipid research 2013
Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families: Two novel mutations in apolipoprotein C3
AE Bochem, JC Capelleveen, GM Dallinga-Thie, AW Schimmel, MM Motazacker, I Tietjen, RR Singaraja, MR Hayden, JJ Kastelein, ES Stroes, GK Hovingh
Clinical Genetics 2013
Innovative technique for the direct determination of proteins in calcified aortic valves
L Coufalova, S Kuckova, M Velcovska, A Zeman, M Smid, M Havelcova, R Hynek
Analytical and Bioanalytical Chemistry 2013
A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates
I Tachmazidou, G Dedoussis, L Southam, AE Farmaki, GR Ritchie, DK Xifara, A Matchan, K Hatzikotoulas, NW Rayner, Y Chen, TI Pollin, JR O'Connell, LM Yerges-Armstrong, C Kiagiadaki, K Panoutsopoulou, J Schwartzentruber, L Moutsianas, , E Tsafantakis, C Tyler-Smith, G McVean, Y Xue, E Zeggini
Nature Communications 2013
Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets
M Larsson, E Vorrsjo, P Talmud, A Lookene, G Olivecrona
The Journal of biological chemistry 2013
Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol
I Tietjen, GK Hovingh, RR Singaraja, C Radomski, A Barhdadi, J McEwen, E Chan, M Mattice, A Legendre, PL Franchini, MP Dubé, JJ Kastelein, MR Hayden
PloS one 2012
Metabolic, hormonal and stress-related molecular changes in <i>post-mortem</i> pituitary glands from schizophrenia subjects
D Krishnamurthy, LW Harris, Y Levin, TA Koutroukides, H Rahmoune, S Pietsch, N Vanattou-Saifoudine, FM Leweke, PC Guest, S Bahn
World Journal of Biological Psychiatry 2012
Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production :
Z Yao, Y Wang
Current Opinion in Lipidology 2012
Uremia Alters HDL Composition and Function
M Holzer, R Birner-Gruenberger, T Stojakovic, D El-Gamal, V Binder, C Wadsack, A Heinemann, G Marsche
Journal of the American Society of Nephrology : JASN 2011
Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins
W Qin, M Sundaram, Y Wang, H Zhou, S Zhong, CC Chang, S Manhas, EF Yao, RJ Parks, PJ McFie, SJ Stone, ZG Jiang, C Wang, D Figeys, W Jia, Z Yao
The Journal of biological chemistry 2011
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content
A Peter, K Kantartzis, F Machicao, J Machann, S Wagner, S Templin, I Königsrainer, A Königsrainer, F Schick, A Fritsche, HU Häring, N Stefan
International Journal of Obesity 2011
Henry's Clinical Diagnosis and Management by Laboratory Methods
JL Miller, AK Rao
Henry's Clinical Diagnosis and Management by Laboratory Methods 2011
Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins: EVIDENCE THAT ApoC-III PLAYS A MAJOR ROLE IN THE FORMATION OF LIPID PRECURSORS WITHIN THE MICROSOMAL LUMEN
W Qin, M Sundaram, Y Wang, H Zhou, S Zhong, CC Chang, S Manhas, EF Yao, RJ Parks, PJ McFie, SJ Stone, ZG Jiang, C Wang, D Figeys, W Jia, Z Yao
The Journal of biological chemistry 2011
Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia
M Sundaram, S Zhong, MB Khalil, H Zhou, ZG Jiang, Y Zhao, J Iqbal, MM Hussain, D Figeys, Y Wang, Z Yao
Journal of lipid research 2010
Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia
M Sundaram, S Zhong, MB Khalil, H Zhou, ZG Jiang, Y Zhao, J Iqbal, MM Hussain, D Figeys, Y Wang, Z Yao
Journal of lipid research 2010
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia
AB Cefalù, D Noto, L Magnolo, E Pinotti, M Gomaraschi, S Martini, GB Vigna, L Calabresi, P Tarugi, MR Averna
Atherosclerosis 2009
Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships
ST Turner, M Fornage, CR Jack, TH Mosley, DS Knopman, SL Kardia, E Boerwinkle, M Andrade
Archives of neurology 2009
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
TI Pollin, CM Damcott, H Shen, SH Ott, J Shelton, RB Horenstein, W Post, JC McLenithan, LF Bielak, PA Peyser, BD Mitchell, M Miller, JR O'Connell, AR Shuldiner
Science 2008
Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkers
GL Nelsestuen, SB Harvey, Y Zhang, RS Kasthuri, AR Sinaiko, EW Ely, GR Bernard, M Homoncik, B Jilma
PROTEOMICS – CLINICAL APPLICATIONS 2008
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
DC Chan, MM Chen, EM Ooi, GF Watts
International Journal of Clinical Practice 2008
Structure and Dynamics of Human Apolipoprotein CIII
CS Gangabadage, J Zdunek, M Tessari, S Nilsson, G Olivecrona, SS Wijmenga
The Journal of biological chemistry 2008
Overexpression of apolipoprotein CIII increases and CETP reverses diet-induced obesity in transgenic mice
AG Salerno, TR Silva, ME Amaral, LC Alberici, ML Bonfleur, PR Patrício, EP Francesconi, DM Grassi-Kassisse, AE Vercesi, AC Boschero, HC Oliveira
International Journal of Obesity 2007
A functional polymorphism of apolipoprotein C1 detected by mass spectrometry
MS Wroblewski, JT Wilson-Grady, MB Martinez, RS Kasthuri, KR McMillan, C Flood-Urdangarin, GL Nelsestuen
FEBS Journal 2006
Plasma protein profiling: Unique and stable features of individuals
GL Nelsestuen, Y Zhang, MB Martinez, NS Key, B Jilma, M Verneris, A Sinaiko, RS Kasthuri
PROTEOMICS 2005
International Review of Neurobiology
ZT Bloomgarden
International review of neurobiology 2005
Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia
JS Cohn, M Tremblay, R Batal, H Jacques, C Rodriguez, G Steiner, O Mamer, J Davignon
Atherosclerosis 2004
The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?
KW van Dijk, PC Rensen, PJ Voshol, LM Havekes
Current Opinion in Lipidology 2004
Apolipoprotein C-III Isofocusing in the Diagnosis of Genetic Defects in O-Glycan Biosynthesis
S Wopereis, S Grünewald, E Morava, JM Penzien, P Briones, MT Garcı́a-Silva, PN Demacker, KM Huijben, RA Wevers
Clinical chemistry 2003
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
A Onat, G Hergenç, V Sansoy, M Fobker, K Ceyhan, S Toprak, G Assmann
Atherosclerosis 2003
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
S Yamashita, T Maruyama, K Hirano, N Sakai, N Nakajima, Y Matsuzawa
Atherosclerosis 2000
Characterization of Recombinant Wild Type and Site-Directed Mutations of Apolipoprotein C-III: Lipid Binding, Displacement of ApoE, and Inhibition of Lipoprotein Lipase
H Liu, PJ Talmud, L Lins, R Brasseur, G Olivecrona, F Peelman, J Vandekerckhove, M Rosseneu, C Labeur
Biochemistry 2000
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects
R Batal, M Tremblay, PH Barrett, H Jacques, A Fredenrich, O Mamer, J Davignon, JS Cohn
Journal of lipid research 2000
Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr
H Liu, C Labeur, CF Xu, R Ferrell, L Lins, R Brasseur, M Rosseneu, KM Weiss, SE Humphries, PJ Talmud
Journal of lipid research 2000
Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation
B Noll, R Hackler, M Pelzer, S Pelzer, P Nusser, B Maisch, JR Schaefer, A Steinmetz
Clinical Chemistry and Laboratory Medicine 1999
Fast C18 solid-phase desalting/delipidation of the human serum apolipoproteins for matrix-assisted laser desorption ionization and electrospray ionization mass spectrometric analysis
LK Watkins, PV Bondarenko, DC Barbacci, S Song, SL Cockrill, DH Russell, RD Macfarlane
Journal of Chromatography A 1999
Role of ApoCs in Lipoprotein Metabolism: Functional Differences Between ApoC1, ApoC2, and ApoC3
MC Jong, MH Hofker, LM Havekes
Arteriosclerosis, thrombosis, and vascular biology 1999
Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein
PV Bondarenko, SL Cockrill, LK Watkins, ID Cruzado, RD Macfarlane
Journal of lipid research 1999
Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro
J Björkegren, F Karpe, S Vitols, P Tornvall, A Hamsten
Journal of lipid research 1998
A novel apolipoprotein C-III variant, apoC-III(Gln38–>Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin
CR Pullinger, MJ Malloy, AK Shahidi, M Ghassemzadeh, P Duchateau, J Villagomez, J Allaart, JP Kane
Journal of lipid research 1997
Gene-diet interaction in determining plasma lipid response to dietary intervention
JM Ordovas, J Lopez-Miranda, P Mata, F Perez-Jimenez, AH Lichtenstein, EJ Schaefer
Atherosclerosis 1995
Characterization of Apolipoproteins B-100, AI and C from Plasma Lipoprotein in the Goose, Anser anser. Evidence for a Genetic Polymorphism in ApoC-like Apolipoproteins
D Hermier, N Sellier, D Rousselot-Pailley, P Forgez
European Journal of Biochemistry 1995
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia: Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase
K Hirano, S Yamashita, Y Kuga, N Sakai, S Nozaki, S Kihara, T Arai, K Yanagi, S Takami, M Menju, M Ishigami, Y Yoshida, K Kameda-Takemura, K Hayashi, Y Matsuzawa
Arteriosclerosis, thrombosis, and vascular biology 1995
Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol
A Inazu, XC Jiang, T Haraki, K Yagi, N Kamon, J Koizumi, H Mabuchi, R Takeda, K Takata, Y Moriyama
Journal of Clinical Investigation 1994
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels
JC Cohen, Z Wang, SM Grundy, MR Stoesz, R Guerra
Journal of Clinical Investigation 1994
Familial lipoprotein disorders and premature coronary artery disease
EJ Schaefer, JJ Genest, JM Ordovas, DN Salem, PW Wilson
Atherosclerosis 1994
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg
1994
Principles and Treatment of Lipoprotein Disorders
G Schettler, AJ Habenicht
1994
Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E
HV de Silva, SJ Lauer, J Wang, WS Simonet, KH Weisgraber, RW Mahley, JM Taylor
The Journal of biological chemistry 1994
Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45–>Asn), in a Turkish patient
S Lüttmann, A von Eckardstein, W Wei, H Funke, E Köhler, RW Mahley, G Assmann
Journal of lipid research 1994
Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia
DJ Rader, JR Schaefer, P Lohse, K Ikewaki, F Thomas, WA Harris, LA Zech, CA Dujovne, HB Brewer
Metabolism 1993
Nucleotide sequences of the Macaca fascicularis apolipoprotein C-III and A-IV genes
J Osada, M Pocoví, RJ Nicolosi, EJ Schaefer, JM Ordovás
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1993
Advances in Human Genetics 21
H Harris, K Hirschhorn
1993
Metabolic and genetic control of HDL cholesterol levels
AR Tall
Journal of Internal Medicine 1992
Determination of Apolipoprotein B in Apolipoprotein CII/CIII-Containing Lipoproteins by an Immunoenzymmetric Assay
M Sandkamp, BM Tambyrajah, G Assmann, H Schriewer
Clinical Chemistry and Laboratory Medicine 1992
Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III
A von Eckardstein, M Walter, H Holz, A Benninghoven, G Assmann
Journal of lipid research 1991

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts